JB
DSGN icon

Julian Baker’s Design Therapeutics DSGN Stock Holding History

Julian Baker’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.8M Buy
2,678,430
+92,452
+4% +$1.15M 0.19% 42
2026
Q1 		$27.5M Buy
2,585,978
+352,879
+16% +$3.57M 0.16% 44
2025
Q4 		$20.9M Buy
2,233,099
+520,217
+30% +$4.07M 0.12% 51
2025
Q3 		$12.9M Hold
1,712,882
– – 0.09% 60
2025
Q2 		$5.77M Sell
1,712,882
-30,843
-2% -$115K 0.06% 64
2025
Q1 		$6.73M Hold
1,743,725
– – 0.07% 55
2024
Q4 		$10.8M Hold
1,743,725
– – 0.11% 52
2024
Q3 		$9.38M Buy
1,743,725
+48,431
+3% +$228K 0.1% 54
2024
Q2 		$5.68M Buy
1,695,294
+33,174
+2% +$129K 0.07% 60
2024
Q1 		$6.7M Buy
1,662,120
+162,120
+11% +$433K 0.08% 59
2023
Q4 		$3.98M Hold
1,500,000
– – 0.05% 64
2023
Q3 		$3.54M Buy
1,500,000
+1,000,000
+200% +$4.66M 0.02% 73
2023
Q2 		$3.15M Sell
500,000
-126,884
-20% -$776K 0.02% 86
2023
Q1 		$3.62M Sell
626,884
-65,247
-9% -$488K 0.02% 77
2022
Q4 		$7.1M Sell
692,131
-744,505
-52% -$10.1M 0.04% 69
2022
Q3 		$24M Hold
1,436,636
– – 0.16% 41
2022
Q2 		$20.1M Hold
1,436,636
– – 0.11% 48
2022
Q1 		$23.2M Hold
1,436,636
– – 0.13% 48
2021
Q4 		$30.8M Hold
1,436,636
– – 0.15% 46
2021
Q3 		$21.1M Hold
1,436,636
– – 0.09% 61
2021
Q2 		$28.6M Hold
1,436,636
– – 0.13% 57
2021
Q1 		$43M Buy
+1,436,636
New +$48.5M 0.19% 43

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

Julian Baker's DSGN Position: Q2 2026 in Review

Julian Baker increased its Design Therapeutics (DSGN) stake by 3.6% in Q2 2026, buying an estimated $1.15M and bringing the position to 2,678,430 shares worth $38.8M. The position accounts for 0.19% of the portfolio, ranked #42.

Julian Baker first reported a position in DSGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $43M in Q1 2021. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Julian Baker held 2,678,430 shares of Design Therapeutics worth $38.8M as of Q2 2026.
  • Julian Baker bought 92,452 Design Therapeutics shares in Q2 2026, an estimated $1.15M.
  • Design Therapeutics made up 0.19% of Julian Baker's portfolio in Q2 2026, its #42 holding.
  • Julian Baker first reported a position in Design Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Julian Baker's Design Therapeutics position peaked at $43M in Q1 2021.
  • 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.